IONS

Ionis Pharmaceuticals
IONS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$6.33B
EV
$6.15B
Shares Outstanding
159.16M
Beta
0.23

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$57.66
P/E 2025E
-
P/Revenue 2025E
8.41x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ionis Pharmaceuticals, Inc.

gainify
IONS

Ionis Pharmaceuticals, Inc.

IONS

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused...

Sector

Healthcare

Industry

Biotechnology

CEO

Monia, Brett

Employees

1,069

IPO Date

1991-05-17

Headquarters

2855 Gazelle Court, Carlsbad, California, 92010, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.